Recent News from NEWGLAB Pharma

April 2020

Acquired ODD status for liver cancer and intrahepatic bile duct cancer and License-In for additional Indications.

Dietary supplement sales contract with KoDiscovery and Sales started in March.

December 2019

Seminars about Anti- Bacteria Treatment using 3BP with the University of Wroclaw, Poland.

For more information, visit NEWGLAB Pharma’s homepage here.